Article Versions Notes

de Araújo RSA, Carmo JdOdS, de Omena Silva SL, Costa da Silva CRA, Souza TPM, Mélo NBd, Bourguignon J-J, Schmitt M, Aquino TMd, Rodarte RS, et al. Coumarin Derivatives Exert Anti-Lung Cancer Activity by Inhibition of Epithelial–Mesenchymal Transition and Migration in A549 Cells. Pharmaceuticals. 2022; 15(1):104. https://doi.org/10.3390/ph15010104

de Araújo, Rodrigo Santos Aquino, Julianderson de Oliveira dos Santos Carmo, Simone Lara de Omena Silva, Camila Radelley Azevedo Costa da Silva, Tayhana Priscila Medeiros Souza, Natália Barbosa de Mélo, Jean-Jacques Bourguignon, Martine Schmitt, Thiago Mendonça de Aquino, Renato Santos Rodarte, and et al. 2022. "Coumarin Derivatives Exert Anti-Lung Cancer Activity by Inhibition of Epithelial–Mesenchymal Transition and Migration in A549 Cells" Pharmaceuticals 15, no. 1: 104. https://doi.org/10.3390/ph15010104

de Araújo, R. S. A., Carmo, J. d. O. d. S., de Omena Silva, S. L., Costa da Silva, C. R. A., Souza, T. P. M., Mélo, N. B. d., Bourguignon, J. -J., Schmitt, M., Aquino, T. M. d., Rodarte, R. S., Moura, R. O. d., Barbosa Filho, J. M., Barreto, E., & Mendonça-Junior, F. J. B. (2022). Coumarin Derivatives Exert Anti-Lung Cancer Activity by Inhibition of Epithelial–Mesenchymal Transition and Migration in A549 Cells. Pharmaceuticals, 15(1), 104. https://doi.org/10.3390/ph15010104